Under the Brand name Balanced2Day – Superior CBD at Affordable Prices
LAS VEGAS, NV / ACCESSWIRE / November 17, 2020 / Megola, Inc. (OTC PINK:MGON) (the “Company”), a Consortium Group of Health Technologies and Services Company is pleased to enter the multi-billion dollar CBD Industry with its leading Premium Hemp Extract products under the brand name Balanced2Day (B2D). The products, now available at Balanced2Day.com, come in a variety of forms and formulations to help boost energy, manage pain, reduce stress, anxiety, insomnia, and many other benefits that CBD has to offer.
“We are excited to offer our Balanced2Day brand of CBD products. Produced in the USA, we offer true seed to sale Premium Hemp that is non GMO, Gluten free, Vegan and Third-Party lab tested. The CBD market is maturing as people are becoming more aware and educated about the significant health benefits of CBD products. We are excited to be a part of the growing CBD Hemp market in North America offering superior quality products at affordable prices.” states Megola CEO Robert Gardiner.
About Balanced2Day Brand
Our BRAND was built on the belief that the road to recovery begins with natural solutions, and we proudly stand behind the healing powers of hemp. Our mission is to optimize everyday performance and challenge individuals to rethink the healing process by creating products that promote wellness, balance and recovery.
Balanced2Day is an expanding E-commerce CBD brand designed for athletes and individuals leading active lifestyles. Every bottle of Balanced2Day is pesticide-free, chemical-free, preservative-free, and THC-free and legal in all 50 states. Grown and extracted in the USA, our quality CBD is fully compliant under the Kentucky Department of Agricultural Industrial Hemp Pilot Program.1
1Section 7606 of the Agricultural Act of 2014 (“Farm Bill”)
Balanced2Day Sport tinctures are easy to use and available in a range of potency levels. Based on sublingual (under the tongue) absorption and the addition of the short chain amino acid MCT oil, tinctures are one of the fastest acting consumption methods. Each bottle includes a dropper that provides both flexibility and precision of dosage. These tinctures can also be mixed into a beverage, smoothie, or other kinds of food for ingestion.
Premium Hemp Extract is great for reducing the pain from exercise-induced inflammation, supporting muscle and joint health, and alleviating everyday stress and tension. By combining our state-of- the-art, whole hemp extract with luxurious ingredients, we offer creams that feel good on the skin and provide deep, penetrating relief. The topical allows for direct application to affected areas of the body.
Balanced2Day Hemp Extract Pet Products were formulated with your Pets in mind, to give them natural relief. Our pet products are crafted with our pure Hemp Extract and natural flavorings, making them the perfect treat for your pets and are made with our 99%+ pure Hemp Extract and MCT Coconut Oil that supports joint health.
Third Party Testing
We believe in 100% transparency with our customers and affiliates. Every batch of product gets sent out for Third Party Testing before we pick, pack, and ship the product to the end user.
For More Information go to : Balanced2Day.com
The CBD Market
Cannabidiol (CBD) Market size exceeded USD 2.8 billion in 2019 and is set to grow at around 52.7% CAGR between 2020 and 2026. Cannabidiol is a compound found in hemp plants which is being utilized due to its therapeutic properties in humans.
CBD and COVID-19
In recent months, several CBD-focused companies have begun studies to determine if
CBDs can be used to treat symptoms of COVID-19, which has infected nearly 21M
worldwide. In the last two months alone:
A study by Augusta University (GA) have completed animal studies suggesting CBDs could provide positive results for acute respiratory distress syndrome 2
A preclinical study by the University of Lethbridge in Alberta, Canada indicates a number of CBD strains could impact COVID-19 infections 3
The University of Nebraska and Texas Biomedical Research Institute have stated CBDs could treat lung infections in COVID-19 patients 4
The University of Maryland School of Medicine has established a lab specifically to study the effect of CBDs on COVID-19 as an anti-inflammatory 5
2Augusta University – CBD may help avert lung destruction in COVID-19
3Preclinical study by the University of Lethbridge in Alberta – CBD strains could impact COVID-19 infections
4University of Nebraska and Texas Biomedical Research Institute – CBDs could treat lung infections in COVID-19 patients
5University of Maryland School of Medicine – Effect of CBDs on COVID-19 as an anti-inflammatory
Recent Megola News
LAS VEGAS, NV. November 10, 2020 Megola, Inc. (OTC:MGON) (the “Company”), a Consortium Group of Health Technologies and Services Company is pleased to update that NEW Inventory is now available for our DIY portable Disinfectant/Deodorizing/Sanitizing ozone unit that eliminates toxic compounds. Amid the Global Coronavirus pandemic, public interest has recently increased in the ability of disinfectant and sanitizing ozone devices which can help eliminate infectious agents such as SARS Coronavirus, Bacteria, Influenza, Hemolytic Streptococci and many others sparking the industry’s interest in ozone’s ability to help combat Covid-19.
For more information go to: https://www.geniebrands.com/stink-genie/
Outstanding Shares 196,095,060
Certificates Outstanding 23,097,844
Common Shares Float 172,997,216
For more information Contact:
Attn: John MacLeod
Stock information here: https://www.otcmarkets.com/stock/MGON/overview.
Disclaimer: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement.
SOURCE: Megola, Inc.
View source version on accesswire.com: